Cargando…

Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy

Objective/Methods. To determine the outcomes of invasive neonatal candidiasis before institution of routine antifungal prophylaxis, we conducted a retrospective review of cases of invasive candidiasis in newborns in a referral-based neonatal intensive care unit located in a single tertiary academic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cahan, Heather, Deville, Jaime G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216279/ https://www.ncbi.nlm.nih.gov/pubmed/22121380 http://dx.doi.org/10.1155/2011/813871

Ejemplares similares

808. Outcomes of Invasive Candidiasis Stratified by Antifungal Therapy
por: Box, Maggie, et al.
Publicado: (2023)

Conventional and alternative antifungal therapies to oral candidiasis
por: Anibal, Paula Cristina, et al.
Publicado: (2010)

Initial presentation of tonsillar carcinoma with candidiasis
por: Shih, Cheng-Ping, et al.
Publicado: (2019)

Candidiasis and Mechanisms of Antifungal Resistance
por: Bhattacharya, Somanon, et al.
Publicado: (2020)

Investigation of a Cluster of Candida albicans Invasive Candidiasis in a Neonatal Intensive Care Unit by Pulsed-Field Gel Electrophoresis
por: Ben Abdeljelil, Jihene, et al.
Publicado: (2012)

Epidemiology and antifungal resistance in invasive candidiasis
por: Rodloff, AC, et al.
Publicado: (2011)

Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis
por: da Rosa Monte Machado, Gabriella, et al.
Publicado: (2020)

Systemic neonatal candidiasis.
por: Reid, M., et al.
Publicado: (1991)

Timing of Initiating Glycopeptide Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: The Impact on Clinical Outcome
por: Lee, Chen-Hsiang, et al.
Publicado: (2013)

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

Impact of Previous ART and of ART Initiation on Outcome of HIV-Associated Tuberculosis
por: Girardi, Enrico, et al.
Publicado: (2012)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
por: Mayandi, Venkatesh, et al.
Publicado: (2023)

Antifungal stewardship in critical care: Implementing a diagnostics-driven care pathway in the management of invasive candidiasis
por: Hare, D., et al.
Publicado: (2020)

Risk Factors of Vulvovaginal Candidiasis among Women of Reproductive Age in Xi'an: A Cross-Sectional Study
por: Zeng, Xianling, et al.
Publicado: (2018)

The Microcirculation Is Unchanged in Neonates with Severe Respiratory Failure after the Initiation of ECMO Treatment
por: Top, Anke P. C., et al.
Publicado: (2012)

Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes in Fusarium, Aspergillus and, Dematiaceous Keratitis
por: Gajjar, Devarshi U., et al.
Publicado: (2013)

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016)

Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
por: Lírio, Juliana, et al.
Publicado: (2019)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
por: León-Buitimea, Angel, et al.
Publicado: (2021)

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016)

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates
por: Mohammadi, R, et al.
Publicado: (2016)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
por: Honarvar, Behnam, et al.
Publicado: (2018)

Antifungal Treatment is Not Required for Immunocompetent Individuals With Asymptomatic Esophageal Candidiasis
por: Min, Yang Won, et al.
Publicado: (2015)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs
por: Quindós, Guillermo, et al.
Publicado: (2019)

The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
por: Ordaya, Eloy E., et al.
Publicado: (2023)

An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis
por: Lee, Winnie, et al.
Publicado: (2014)

Neonatal thrush of newborns: Oral candidiasis?
por: Vainionpää, Anne, et al.
Publicado: (2019)

Correction: Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
Publicado: (2019)

Sarcoidosis Treatment with Antifungal Medication: A Follow-Up
por: Terčelj, Marjeta, et al.
Publicado: (2014)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates
por: Hsu, Jen-Fu, et al.
Publicado: (2018)

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
por: Vergidis, Pascalis, et al.
Publicado: (2016)

Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
por: Shah, Neha, et al.
Publicado: (2017)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2020)

Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants
por: Takahashi, Daijiro, et al.
Publicado: (2009)

Esophageal candidiasis and its diagnosis
por: Bansal, Raghav, et al.
Publicado: (2019)

Determinants of Symptomatic Vulvovaginal Candidiasis among Human Immunodeficiency Virus Type 1 Infected Women in Rural KwaZulu-Natal, South Africa
por: Apalata, Teke, et al.
Publicado: (2014)

Systemic Candidiasis and TLR2 Agonist Exposure Impact the Antifungal Response of Hematopoietic Stem and Progenitor Cells
por: Martínez, Alba, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_885iqvb4hhsfq1lm7auvl1rsld